BeyondSpring Inc. SEC filings BYSI

BeyondSpring Inc. has 264 filings in SEC EDGAR's recent list, going back to Jun 30, 2016. Its latest annual report, Form ARS, was filed on Sep 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 13, 2026 (shareholder vote results). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Sep 3, 2026 Dec 31, 2025
10-K Annual report Mar 25, 2026 Dec 31, 2025
10-K Annual report Mar 27, 2025 Dec 31, 2024
20-F Annual report (foreign issuer) Apr 29, 2024 Dec 31, 2023
20-F Annual report (foreign issuer) Apr 18, 2023 Dec 31, 2022
20-F Annual report (foreign issuer) Apr 14, 2022 Dec 31, 2021
20-F Annual report (foreign issuer) Apr 30, 2021 Dec 31, 2020
20-F Annual report (foreign issuer) Apr 30, 2020 Dec 31, 2019
20-F Annual report (foreign issuer) Apr 30, 2019 Dec 31, 2018
20-F/A Amended annual report (foreign issuer) May 16, 2018 Dec 31, 2017
20-F Annual report (foreign issuer) Apr 3, 2018 Dec 31, 2017
20-F Annual report (foreign issuer) Apr 28, 2017 Dec 31, 2016

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BYSI (Nasdaq)
Fiscal year ends
December 31
Headquarters
Florham Park, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1677940

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.